Gedeon Richter Strikes $16.5m Global Tocilizumab Deal

Agreement For Biosimilar To Actemra/RoActemra Reached With Taiwan’s Mycenax

 
• By David Wallace
Tocilizumab_Injections
The deal provides Richter with a rival to Actemra/RoActemra • Source: Shutterstock

More from Deals

More from Business